HGDTI: predicting drug–target interaction by using information aggregation based on heterogeneous graph neural network

Background: In research on new drug discovery, the traditional wet experiment has a long period. Predicting drug–target interaction (DTI) in silico can greatly narrow the scope of search of candidate medications. Excellent algorithm model may be more effective in revealing the potential connection b...

Full description

Bibliographic Details
Main Authors: Cheng, X. (Author), Dai, J. (Author), Lin, W. (Author), Qiu, W. (Author), Xiao, X. (Author), Yu, L. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03313nam a2200469Ia 4500
001 10-1186-s12859-022-04655-5
008 220425s2022 CNT 000 0 und d
020 |a 14712105 (ISSN) 
245 1 0 |a HGDTI: predicting drug–target interaction by using information aggregation based on heterogeneous graph neural network 
260 0 |b BioMed Central Ltd  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1186/s12859-022-04655-5 
520 3 |a Background: In research on new drug discovery, the traditional wet experiment has a long period. Predicting drug–target interaction (DTI) in silico can greatly narrow the scope of search of candidate medications. Excellent algorithm model may be more effective in revealing the potential connection between drug and target in the bioinformatics network composed of drugs, proteins and other related data. Results: In this work, we have developed a heterogeneous graph neural network model, named as HGDTI, which includes a learning phase of network node embedding and a training phase of DTI classification. This method first obtains the molecular fingerprint information of drugs and the pseudo amino acid composition information of proteins, then extracts the initial features of nodes through Bi-LSTM, and uses the attention mechanism to aggregate heterogeneous neighbors. In several comparative experiments, the overall performance of HGDTI significantly outperforms other state-of-the-art DTI prediction models, and the negative sampling technology is employed to further optimize the prediction power of model. In addition, we have proved the robustness of HGDTI through heterogeneous network content reduction tests, and proved the rationality of HGDTI through other comparative experiments. These results indicate that HGDTI can utilize heterogeneous information to capture the embedding of drugs and targets, and provide assistance for drug development. Conclusions: The HGDTI based on heterogeneous graph neural network model, can utilize heterogeneous information to capture the embedding of drugs and targets, and provide assistance for drug development. For the convenience of related researchers, a user-friendly web-server has been established at http://bioinfo.jcu.edu.cn/hgdti. © 2022, The Author(s). 
650 0 4 |a Amino acids 
650 0 4 |a Comparative experiments 
650 0 4 |a Drug development 
650 0 4 |a Drug interactions 
650 0 4 |a Drug–target interaction 
650 0 4 |a Drug-target interactions 
650 0 4 |a Embeddings 
650 0 4 |a Forecasting 
650 0 4 |a Graph neural network 
650 0 4 |a Graph neural networks 
650 0 4 |a Graph neural networks 
650 0 4 |a Heterogeneous graph 
650 0 4 |a Heterogeneous information 
650 0 4 |a Heterogeneous networks 
650 0 4 |a Long short-term memory 
650 0 4 |a Molecular fingerprint 
650 0 4 |a Molecular fingerprint 
650 0 4 |a Network embeddings 
650 0 4 |a Neural network model 
650 0 4 |a Proteins 
650 0 4 |a Pseudo amino acid composition 
650 0 4 |a Pseudo Amino Acid Compositions 
650 0 4 |a Tensors 
700 1 |a Cheng, X.  |e author 
700 1 |a Dai, J.  |e author 
700 1 |a Lin, W.  |e author 
700 1 |a Qiu, W.  |e author 
700 1 |a Xiao, X.  |e author 
700 1 |a Yu, L.  |e author 
773 |t BMC Bioinformatics